J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn’s data

J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn’s data
fkansteiner
Fri, 02/18/2022 – 07:52